BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33260074)

  • 1. Regulative effect of maternal serum fatty acid-binding protein 4 on insulin resistance and the development of gestational diabetes mellitus.
    Duan B; Li Y; Dong K; Sun Y; Ma A; Yang X
    Prostaglandins Leukot Essent Fatty Acids; 2020 Dec; 163():102213. PubMed ID: 33260074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of fatty acid binding protein 4 attenuates gestational diabetes mellitus.
    Dong X; Yang L
    Prostaglandins Leukot Essent Fatty Acids; 2020 Oct; 161():102179. PubMed ID: 32977290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus.
    Ning H; Tao H; Weng Z; Zhao X
    Acta Diabetol; 2016 Dec; 53(6):891-898. PubMed ID: 27147422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma levels of FABP4 and PTEN is associated with more severe insulin resistance in women with gestational diabetes mellitus.
    Li YY; Xiao R; Li CP; Huangfu J; Mao JF
    Med Sci Monit; 2015 Feb; 21():426-31. PubMed ID: 25659997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between Fatty Acid-Binding Protein 4⁻A Proinflammatory Adipokine and Insulin Resistance, Gestational and Type 2 Diabetes Mellitus.
    Trojnar M; Patro-Małysza J; Kimber-Trojnar Ż; Leszczyńska-Gorzelak B; Mosiewicz J
    Cells; 2019 Mar; 8(3):. PubMed ID: 30857223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of serum vitamin D, adipose tissue vitamin D receptor, and peroxisome proliferator-activated receptor γ in women with gestational diabetes mellitus.
    Wang HY; She GT; Sun LZ; Lu H; Wang YP; Miao J; Liu KZ; Sun CF; Ju HH
    Chin Med J (Engl); 2019 Nov; 132(21):2612-2620. PubMed ID: 31651513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity.
    Lan H; Cheng CC; Kowalski TJ; Pang L; Shan L; Chuang CC; Jackson J; Rojas-Triana A; Bober L; Liu L; Voigt J; Orth P; Yang X; Shipps GW; Hedrick JA
    J Lipid Res; 2011 Apr; 52(4):646-56. PubMed ID: 21296956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation.
    Bosquet A; Girona J; Guaita-Esteruelas S; Heras M; Saavedra-García P; Martínez-Micaelo N; Masana L; Rodríguez-Calvo R
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jun; 1863(6):604-613. PubMed ID: 29550588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of fatty acid binding protein 4 alleviates lipid peroxidation and oxidative stress in diabetic retinopathy by regulating peroxisome proliferator-activated receptor γ-mediated ferroptosis.
    Fan X; Xu M; Ren Q; Fan Y; Liu B; Chen J; Wang Z; Sun X
    Bioengineered; 2022 Apr; 13(4):10540-10551. PubMed ID: 35441580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy.
    Catalano PM; Nizielski SE; Shao J; Preston L; Qiao L; Friedman JE
    Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E522-33. PubMed ID: 11832353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex Dimorphic Associations of Gestational Diabetes Mellitus With Cord Plasma Fatty Acid Binding Protein 4 and Estradiol.
    Liu X; Zheng T; Xu YJ; Yang MN; Wang WJ; Huang R; Zhang GH; Guo YN; Zhang J; Ouyang F; Li F; Luo ZC
    Front Endocrinol (Lausanne); 2021; 12():740902. PubMed ID: 34621244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes.
    Rodríguez-Calvo R; Girona J; Rodríguez M; Samino S; Barroso E; de Gonzalo-Calvo D; Guaita-Esteruelas S; Heras M; van der Meer RW; Lamb HJ; Yanes O; Correig X; Llorente-Cortés V; Vázquez-Carrera M; Masana L
    Metabolism; 2019 Jul; 96():12-21. PubMed ID: 30999003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose tissue-derived FABP4 mediates glucagon-stimulated hepatic glucose production in gestational diabetes.
    Ron I; Mdah R; Zemet R; Ulman RY; Rathaus M; Brandt B; Mazaki-Tovi S; Hemi R; Barhod E; Tirosh A
    Diabetes Obes Metab; 2023 Nov; 25(11):3192-3201. PubMed ID: 37449442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.
    Boss M; Kemmerer M; Brüne B; Namgaladze D
    Atherosclerosis; 2015 Jun; 240(2):424-30. PubMed ID: 25897794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of microRNAs in omental adipose tissue from gestational diabetes mellitus subjects reveals miR-222 as a regulator of ERα expression in estrogen-induced insulin resistance.
    Shi Z; Zhao C; Guo X; Ding H; Cui Y; Shen R; Liu J
    Endocrinology; 2014 May; 155(5):1982-90. PubMed ID: 24601884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Gestational Diabetes Mellitus in relation to Plasma Concentrations of Fatty Acid-Binding Protein 4: A Nested Case-Control Study in China.
    Jin C; Lin L; Han N; Zhao Z; Xu X; Luo S; Liu J; Wang H
    J Diabetes Res; 2021; 2021():6681432. PubMed ID: 34368366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FABP4 and I-FABP Levels in Pregnant Women Are Associated with Body Mass Index but Not Gestational Diabetes.
    Vorobjova T; Tagoma A; Talja I; Janson H; Kirss A; Uibo R
    J Diabetes Res; 2022; 2022():1089434. PubMed ID: 35647197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid binding protein 4 regulates intracellular lipid accumulation in human trophoblasts.
    Scifres CM; Chen B; Nelson DM; Sadovsky Y
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1083-91. PubMed ID: 21525163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum from pregnant women with gestational diabetes mellitus increases the expression of FABP4 mRNA in primary subcutaneous human pre-adipocytes.
    Li L; Lee SJ; Kook SY; Ahn TG; Lee JY; Hwang JY
    Obstet Gynecol Sci; 2017 May; 60(3):274-282. PubMed ID: 28534013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in serum adipocyte fatty acid-binding protein in women with gestational diabetes mellitus and normal pregnant women during mid- and late pregnancy.
    Zhang Y; Zhang HH; Lu JH; Zheng SY; Long T; Li YT; Wu WZ; Wang F
    J Diabetes Investig; 2016 Sep; 7(5):797-804. PubMed ID: 27181269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.